<SEC-DOCUMENT>0001193125-20-328750.txt : 20201229
<SEC-HEADER>0001193125-20-328750.hdr.sgml : 20201229
<ACCEPTANCE-DATETIME>20201229164928
ACCESSION NUMBER:		0001193125-20-328750
CONFORMED SUBMISSION TYPE:	FWP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20201229
DATE AS OF CHANGE:		20201229

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MICROVISION, INC.
		CENTRAL INDEX KEY:			0000065770
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				911600822
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		FWP
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-228113
		FILM NUMBER:		201423004

	BUSINESS ADDRESS:	
		STREET 1:		6244 185TH AVENUE NE, SUITE 100
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98052
		BUSINESS PHONE:		425-936-6847

	MAIL ADDRESS:	
		STREET 1:		6244 185TH AVENUE NE, SUITE 100
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98052

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MICROVISION INC
		DATE OF NAME CHANGE:	19960724

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MICROVISION, INC.
		CENTRAL INDEX KEY:			0000065770
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				911600822
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		FWP

	BUSINESS ADDRESS:	
		STREET 1:		6244 185TH AVENUE NE, SUITE 100
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98052
		BUSINESS PHONE:		425-936-6847

	MAIL ADDRESS:	
		STREET 1:		6244 185TH AVENUE NE, SUITE 100
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98052

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MICROVISION INC
		DATE OF NAME CHANGE:	19960724
</SEC-HEADER>
<DOCUMENT>
<TYPE>FWP
<SEQUENCE>1
<FILENAME>d70706dfwp.htm
<DESCRIPTION>FWP
<TEXT>
<HTML><HEAD>
<TITLE>FWP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Issuer Free Writing Prospectus </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Filed Pursuant to Rule 433 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Registration Statement <FONT STYLE="white-space:nowrap">No.&nbsp;333-228113</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">December&nbsp;29, 2020 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">


<IMG SRC="g70706g1229103747108.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>PRESS RELEASE</B></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MicroVision Announces $13 Million
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">At-the-Market</FONT></FONT> Equity Facility </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">REDMOND, Wash. &#150; December&nbsp;29,
2020 &#150; MicroVision, Inc. (NASDAQ: MVIS), a leader in innovative ultra-miniature projection display technology, today announced it entered into a $13&nbsp;million
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">At-the-Market</FONT></FONT> (ATM) equity offering agreement with Craig-Hallum Capital Group on December&nbsp;29, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the agreement MicroVision may, from time to time, at its discretion offer and sell shares of its common stock having an aggregate value of up to
$13&nbsp;million through Craig-Hallum. MicroVision intends to use the net proceeds from the ATM, if any, for general corporate purposes, which may include, but are not limited to, working capital and capital expenditures as MicroVision continues
development of its automotive lidar module and pursues a potential strategic transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Completing development of what we believe will be the
best in class lidar sensor for range, resolution and frame rate is an engineering challenge. So far, our team remains on track to complete our Long Range Lidar sensor sample in April 2021. We believe this financing will further solidify our balance
sheet as we remain committed to pursuing strategic alternatives and establishing value for our shareholders,&#148; said Sumit Sharma, MicroVision Chief Executive Officer. &#147;We expect a stronger balance sheet will provide the Company with runway
through 2021 and into the first quarter of 2022 to enable us to continue development of our lidar sensor while pursuing strategic alternatives,&#148; said Steve Holt, MicroVision Chief Financial Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the ATM equity offering sales agreement, sales of common stock, if any, through Craig-Hallum, will be made by means of ordinary brokers&#146;
transactions, in negotiated transactions, to or through a market maker other than on an exchange or otherwise, at market prices prevailing at the time of sale, at prices related to such prevailing market prices, or at negotiated prices and/or any
other method permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The common stock will be offered under MicroVision&#146;s existing effective shelf registration statement (including a
prospectus) filed with the Securities and Exchange Commission. A prospectus supplement related to the offering has been filed with the Securities and Exchange Commission. Any offer, solicitation or sale will be made only by means of the prospectus
supplement and the accompanying prospectus. Current and potential investors should read the prospectus forming part of the registration statement, the prospectus supplement relating to the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">At-the-Market</FONT></FONT> offering and other documents the company has filed with the SEC for more complete information about MicroVision and the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">At-the-Market</FONT></FONT> offering program. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the prospectus supplement and accompanying prospectus relating to these securities may be obtained
by contacting Craig-Hallum at 222 South Ninth Street, Suite 350, Attention: Equity Capital Markets, by telephone at (612) <FONT STYLE="white-space:nowrap">334-6300</FONT> or by email at prospectus@chlm.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor may there be any sale of MicroVision&#146;s common stock
in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any state or jurisdiction. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About MicroVision </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MicroVision is the creator of PicoP<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;scanning technology, an ultra-miniature sensing and projection solution based on the laser beam scanning methodology pioneered by the Company. MicroVision&#146;s platform approach for this
sensing and display solution means that its technology can be adapted to a wide array of applications and form factors. We combine our hardware, software, and algorithms to unlock value for our customers by providing them a differentiated advanced
solution for a rapidly evolving, <FONT STYLE="white-space:nowrap">always-on</FONT> world. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>MicroVision<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;and PicoP<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;are
registered trademarks of&nbsp;MicroVision, Inc.&nbsp;in&nbsp;the United States&nbsp;and other countries. All other trademarks are the properties of their respective owners. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain statements contained
in this release, including those relating to amounts sold under the ATM and the use of proceeds therefrom, pursuit of strategic alternatives, establishing value for shareholders, strengthening the Company balance sheet, potential cash runway and the
Company&#146;s future products and product applications are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that
could cause actual results to differ materially from those projected in such forward-looking statements include the risk that the Company may not succeed in finding licensing or other strategic solutions, including a potential sale of the Company,
with acceptable timing, benefits or costs; our ability to operate with limited cash or to raise additional capital when needed; market acceptance of our technologies and products or for products incorporating our technologies; the failure of our
commercial partners to perform as expected under our agreements, including from the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> (coronavirus); our ability to identify parties interested in paying any amounts or amounts we deem
desirable for the purchase or license of intellectual property assets; our or our customers&#146; failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with
rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and develop partnership
opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential
product liability claims; our ability to maintain our listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company&#146;s SEC reports, including the Company&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect us. It should be recognized that other factors, including general economic
factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect us to a greater extent than indicated. Except as expressly required by federal securities laws, we undertake no
obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations Contact </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David H. Allen </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Darrow Associates, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">408.427.4463 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">dallen@darrowir.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g70706g1229103747108.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g70706g1229103747108.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "F -<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJFI:E9Z1IT
M^H:A<);VL"[I)7. HKPS6OBEXQ\<WLVF_#[2[B.S0['O!'F1O?<?EC'Z^XH
M]UN]0LK!-]Y>6]LO]Z:4(/U-98\:>%V?8/$6E%O3[6G^-?/<_P #/B#JQ:\U
M&\M)+AADBYO&=S[9P1^M>57=A=6.HSZ?<0LEU!*T,D6,D.#@C\Z /O"WN[:\
MC\RUN(IT/\43AA^8J:OB*,>*_ M[:WABU+2)G.^(R*T8DQCL>&'3(K[$TC7X
M+[PA9Z_.PCAELTN93C(4%06_+F@#9HJ.">*Y@CG@D26&10Z.ARK \@@]Q4E
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MCP.OUQQ^-6Z\P^/EO<S?#&=X'81PW,3S*O\ $F<<_B5- '(:Q\8?$?C+6_\
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H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
